HT Podcast: Inside the HemPoland sale and what’s ahead for CBD?
Pilot Edition PART ONE: Jacek Kramarz, Sales Director at HemPoland, talks about the evolution of the company before it was acquired in August 2018 by…
Medical
Euro CBD market will grow; look for some shakeout globally
Despite significant institutional challenges, the European CBD market will see strong growth for those companies that can navigate the murky waters of EU regulation while…
GW Pharma releases pricing on newly approved CBD-drug
Insured patients in the USA would pay up to $200 per month for CBD-based drug Epidiolex under a recent pricing announcement from the maker, UK-based…
”Democratization of knowledge” will drive demand and data about medical cannabis
The monopoly on medical knowledge previously held by governments, pharma companies and the medical establishment has now been broken forever due to technological advancements and…
Reps from 10 countries will talk CBD at HT’s August biz meet-up
Health care needs to eschew a high-tech approach and go beyond the treatment of symptoms to attack the causes of chronic diseases rooted in current…
After approval of first cannabis-based drug in USA, what’s next?
Recent approval of GW Pharmaceutical’s cannabidiol-based drug Epidiolex in the United States not only will soon give patients needed relief, but can spur further research…
Europe’s Great THC Debate: Get moving or fall behind
EUROPEAN HEMP (Second of 4 parts) Part 1: Europe’s tough row to hoe: Lack of clarity on CBD, THC Upcoming: Part 3: Monday, July 2:…
Medical cannabis, CBD skincare line are next for German company
Berlin-based MH medical hemp GmbH (MH) has applied for licenses to import and sell medical cannabis in German pharmacies, with approval expected this summer. MH…
Hemp advocate in Malawi hints at presidential bid
Hemp activist Ras Chikomeni Chirwa says he may join Malawi’s presidential race next year as an independent candidate. While Chirwa, an elder in the Nyabinghi…
S. African hemp firm moves into MMJ
You need to login to view this content. Please Login. Not a Member? Join Us